Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2003-02-14
2008-03-04
Nickol, Gary B. (Department: 1646)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C530S333000, C530S333000, C435S069100, C435S320100, C435S252300, C435S325000, C435S235100
Reexamination Certificate
active
07339046
ABSTRACT:
The present invention offers new therapies for treating Cystic Fibrosis (CF), that are based on novel DNA molecules and proteins encoded by the DNA molecules. The present invention features DNA molecules encoding CFTR having a partially deleted R domain. The partial deletions in the R domain are between residues 708 and 835 of the wild-type CFTR.
REFERENCES:
Welsh, M. et al, “Cystic Fibrosis”, (1995),McGraw-Hill Health Professions Division, 3: (3799-3839).
Karp PH, Moninger TO, Weber SP, Nesselhauf TS, Launspach JL, Zabner J, Welsh MJ. An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Methods Mol Biol 2002;188:115-37.
Baldursson O, Ostedgaard LS, Rokhlina T, Cotton JF, Welsh MJ. Cystic fibrosis transmembrane conductance regulator C1-channels with R domain deletions and translocations show phosphorylation-dependent and independent activity. J Biol Chem 2001;276(3):1904-1910.
Davies JC, Geddes DM, Alton EW. Gene therapy for cystic fibrosis. J Gene Med 2001;3(5):409-417.
Halbert CL, Allen JM, Miller AD. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 2001;75(14):6615-6624.
Nagel G, Szellas T, Riordan JR, Friedrich T, Hartung K. Non-specific activation of the epithelial sodium channel by the CFTR chloride channel. EMBO Rep 2001;2(3):249-254.
Ostedgaard LS, Baldursson O, Welsh MJ. Regulation of the cystic fibrosis transmembrane conductance regulator C1-channel by its R domain. J Biol Chem 2001;276(11):7689-7692.
Walters RW, Yi SM, Keshavjee S, Brown KE, Welsh MJ, Chiorini JA, Zabner J. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 2001;276(23):20610-20616.
Athanasopoulos T, Fabb S, Dickson G. Gene therapy vectors based on adeno-associated virus: characteristics and applications to acquired and inherited diseases (review). Int J Mol Med 2000;6(4):363-375.
Carter PJ, Samulski RJ. Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 2000;6(1):17-27.
Csanady L, Chan KW, Seto-Young D, Kopsco DC, Nairn AC, Gadsby DC. Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains. J Gen Physiol 2000;116:477-500.
Ma J. Stimulatory and inhibitory functions in the R domain of CFTR chlorine channel. News Physiol Sci 2000;154-158.
Ostedgaard LS, Baldursson O, Vermeer DW, Welsh MJ. A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution. Proc Natl Acad Sci U.S.A. 2001;97(10):5657-5662.
Welsh MJ et al. The Metabolic and Molecular Basis of Inherited Disease. eds. Scirver, Beaudet, Sly, Valle, Childs & Vogelstein 2000;(McGraw-Hill, New York) pp. 5121-5189.
Xie J, Zhao J, Davis PB, Ma J. Conformation, independent of charge, in the R domain affects cystic fibrosis transmembrane conductance regulator channel openings. Biophys J 2000;78(3):1293-1305.
Zabner J, Seiler M, Walters R, Kotin RM, Fulgeras W, Davidson BL, Chiorini JA. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol 2000;74(8):3852-3858.
Chang XB, Cui L, Hou YX, Jensen TJ, Aleksandrov AA, Mengos A, Riordan JR. Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. Mol Cell 1999;4(1):137-142.
Flotte TR. Gene therapy for cystic fibrosis. Curr Opin Mol Ther, 1999;1(4):510-516.
Gadsby DC, Nairn AC. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev 1999;79(1):S77-S107.
Ostedgaard LS, Zeiher B, Welsh MJ. Processing of CFTR bearing the P574H mutation differs from wild-type and deltaF508-CFTR. J Cell Sci, 1999;112(Pt 13):2091-2098.
Schwiebert EM, Benos DJ, Egan ME, Stutts MJ, Guggino WB. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 1999;79(1 Suppl):S145-166.
Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999;79(1 Suppl):S23-S45.
Vankeerberghen A, Lin W, Jaspers M, Cuppens H, Nilius B, Cassiman JJ. Functional characterization of the CFTR R domain using CFTR/MDR1 hybrid and deletion constructs. Biochemistry 1999;38(45):14988-14998.
Walters RW, Grunst T, Bergelson JM, Finberg RW, Welsh MJ, Zabner J. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem 1999;274(15):10219-10226.
Fasbender A, Lee JH, Walters RW, Moniger TO, Zabner J, Welsh MJ. Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest 1998;102(1):184-193.
Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998;72(2):1438-1445.
Vankeerberghen A, Wei L, Jaspers M, Cassimm JJ, Nilius B, Cuppens H. Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum Mol Genet 1998;7(11):1761-1769.
Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell 1998;2(3):397-403.
Zhang L, Wang D, Fischer H, Fan PD, Widdicombe JH, Kan YW, Dong JY. Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc Natl Acad Sci U S A 1998 18;95(17):10158-10163.
Ma J, Zhao J, Drumm ML, Xie J, Davis PB. Function of the R domain in the cystic fibrosis transmembrane conductance regulator chloride channel. J Biol Chem 1997;272:28133-28141.
Winter MC, Welsh MJ. Stimulation of CFTR activity by its phosphorylated R domain. Nature 1997;389(6648):294-296.
Wilkinson DJ, Strong TV, Mansoura MK, Wood DL, Smith SS, Collins FS, Dawson DC. CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol 1997;273(1 Pt):L127-L133.
Dong JY, Fan PD, Frizzell RA. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther 1996;7(17):2101-2112.
Carson MR, Travis SM, Welsh MJ. The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity. J Biol Chem 1995;270(4):1711-1717.
Johnson LG, Boyles SE, Wilson J, Boucher RC. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J Clin Invest 1995;95(3):1377-1382.
Phelps SF, Hauser MA, Cole NM, Rafael JA, Hinkle RT, Faulkner JA, Chamberlain JS. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum Mol Genet 1995;4(8):1251-1258.
Zeiher BG, Eichwald E, Zabner J, Smith JJ, Puga AP, McCray PB, Jr., Capecchi MR, Welsh MJ, Thomas KR. A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest 1995;96(4):2051-2064.
Boucher RC. Human airway ion transport. Part One Am J Respir Crit Care Med 1994;150(1):271-281.
Flotte TR, Afione SA, Solow R, Drumm ML, Markakis D, Guggino WB, Zeitlin PL, Carter BJ. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 1993;268(5):3781-3790.
Rich DP, Gregory RJ, Cheng SH, Smith AE, Welsh MJ. Effect of delection mutations on the function of CFTR chloride channels. Receptors Channels 1993;1:221-232.
Blobel CP, Wolfsberg TG, Turck CW, Myles DG, Primakoff P, White JM. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 1992;356(6366):248-252.
Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Topics Microbiol Immunol 1992;158:97-129.
Rosenf
Ostedgaard Lynda S.
Welsh Michael J.
Zabner Joseph
Arent & Fox LLP
Basi Nirmal S.
Nickol Gary B.
University of Iowa Research Foundation
LandOfFree
CFTR with a partially deleted R domain and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CFTR with a partially deleted R domain and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CFTR with a partially deleted R domain and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3973437